EWSR1 and Ewing sarcoma: Indeed, initial Ewing sarcoma cell line viability assays demonstrated YK-4-279 anti-proliferative IC50 (half maximal inhibitory concentration) values of 0.5–2 μM, yet dissociation of EWS/FLI from RHA was achieved only following 10 μM YK-4-279 treatment22.